Related Experiment Video
Updated: Jan 7, 2026
Methods for Studying Uterine Contributions to Pregnancy Establishment in an Ovariectomized Mouse Model
Published on: April 7, 2023
Provision of contraceptive prescriptions following medication abortion in Australian general practice: A National
Gizat M Kassie1, Danielle Mazza2, Kristina Edvardsson3
1College of Medicine and Public Health, Flinders University, SA, Australia; SAHMRI Women and Kids, South Australian Health and Medical Research Institute, SA, Australia.
Objectives:
To assess longitudinal trends in contraceptive prescribing following medication abortion (MA) in general practice.
Study Design:
Retrospective cohort study of patients aged 14-49 years who were provided MA in the Australian general practice setting between 2013 and 2022. Data, including prescribed medications, were sourced from the national general practice dataset, MedicineInsight. The primary outcome was the proportion prescribed a contraceptive within 60 days of MA.
Results:
Among 4543 undergoing MA, 1841 (40.5%) received a contraceptive prescription within 60 days, with a modest increase over time from 32.0% in 2013-41.3% in 2022. Among those prescribed contraceptives, the most common types were the combined oral contraceptive pill (34.0%), levonorgestrel intrauterine device (27.0%), implant (24.6%) and injection (11.2%), with 931 (50.6%) of prescriptions provided on the same day as MA. The likelihood of receiving a contraceptive prescription was higher among those aged 14-19 years (RR 1.40; 1.21-1.62) and 20-24 years (RR 1.20; 1.08-1.34) compared with the 30-34-year-old group, and in those who were existing patients than new to the practice at time of MA provision (RR 1.15; 1.02-1.31). A positive linear relationship was observed between increasing socioeconomic status and increasing remoteness and higher rates of contraceptive prescription (both p < 0.001).
Conclusions:
Less than half of patients undergoing MA in the general practice setting are provided a contraceptive prescription within 60 days of MA, most commonly the combined oral contraceptive pill. A most increase in contraceptive provision is evident over time, with provision varying significantly according to contraceptive type and patient characteristics.
Implications:
Further research is required to understand underlying reasons for observed variation in contraceptive provision following MA in the general practice setting to ensure all individuals are being provided access to appropriate contraceptive information and services as part of high-quality abortion care.
More Related Videos
Related Concept Videos
01:22Birth Control Methods
01:02Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
01:19Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
01:27Ovarian Cycle
01:22Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...